Physician Leroy Hood, MD, PhD, shares his vision of genomics-driven, proactive, wellness-focused medicine in keynote address
Commentary: Generic Drugs Can Increase Opportunities for Medication Errors
Why dispensing pharmacies should provide color chart of generic drugs they substitute each month
Congress Can Begin Work to Advance Rheumatology Before New Year
Medicare Advantage plans, specialty tier drug spending, SGR repeal, biomedical research funding issues on lawmakers’ plates
Steps to Help Rheumatologists Achieve Office Compliance in Laboratory Coding
A guide to ensure proper coding, billing and accurately diagnose patients.
Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis
New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
When Will Generic Biologic Drugs Become Commercially Available?
Biosimilars are challenging to produce, but progress is being made
Rheumatology Drug Research Should Focus on Particular Groups of Patients
An analysis of risks and benefits of drugs in specific types of patients will help rheumatologists provide better treatment
What You Need to Know About a Proposed Risk Evaluation and Mitigation Strategy Program for Opioid Analgesics
The U.S. Food and Drug Administration favors enacting a mandatory opioid-prescribing training program for dispensers of the extended-release and long-acting analgesics
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 10
- Next Page »